UniProt ID | TRPC4_HUMAN | |
---|---|---|
UniProt AC | Q9UBN4 | |
Protein Name | Short transient receptor potential channel 4 | |
Gene Name | TRPC4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 977 | |
Subcellular Localization |
Membrane Multi-pass membrane protein. Cell membrane Multi-pass membrane protein. Enhanced insertion into the cell membrane after activation of the EGF receptor. |
|
Protein Description | Form a receptor-activated non-selective calcium permeant cation channel. Acts as a cell-cell contact-dependent endothelial calcium entry channel. Probably operated by a phosphatidylinositol second messenger system activated by receptor tyrosine kinases or G-protein coupled receptors. Mediates cation entry, with an enhanced permeability to barium over calcium. May also be activated by intracellular calcium store depletion.. | |
Protein Sequence | MAQFYYKRNVNAPYRDRIPLRIVRAESELSPSEKAYLNAVEKGDYASVKKSLEEAEIYFKININCIDPLGRTALLIAIENENLELIELLLSFNVYVGDALLHAIRKEVVGAVELLLNHKKPSGEKQVPPILLDKQFSEFTPDITPIILAAHTNNYEIIKLLVQKGVSVPRPHEVRCNCVECVSSSDVDSLRHSRSRLNIYKALASPSLIALSSEDPFLTAFQLSWELQELSKVENEFKSEYEELSRQCKQFAKDLLDQTRSSRELEIILNYRDDNSLIEEQSGNDLARLKLAIKYRQKEFVAQPNCQQLLASRWYDEFPGWRRRHWAVKMVTCFIIGLLFPVFSVCYLIAPKSPLGLFIRKPFIKFICHTASYLTFLFLLLLASQHIDRSDLNRQGPPPTIVEWMILPWVLGFIWGEIKQMWDGGLQDYIHDWWNLMDFVMNSLYLATISLKIVAFVKYSALNPRESWDMWHPTLVAEALFAIANIFSSLRLISLFTANSHLGPLQISLGRMLLDILKFLFIYCLVLLAFANGLNQLYFYYEETKGLTCKGIRCEKQNNAFSTLFETLQSLFWSIFGLINLYVTNVKAQHEFTEFVGATMFGTYNVISLVVLLNMLIAMMNNSYQLIADHADIEWKFARTKLWMSYFEEGGTLPTPFNVIPSPKSLWYLIKWIWTHLCKKKMRRKPESFGTIGRRAADNLRRHHQYQEVMRNLVKRYVAAMIRDAKTEEGLTEENFKELKQDISSFRFEVLGLLRGSKLSTIQSANASKESSNSADSDEKSDSEGNSKDKKKNFSLFDLTTLIHPRSAAIASERHNISNGSALVVQEPPREKQRKVNFVTDIKNFGLFHRRSKQNAAEQNANQIFSVSEEVARQQAAGPLERNIQLESRGLASRGDLSIPGLSEQCVLVDHRERNTDTLGLQVGKRVCPFKSEKVVVEDTVPIIPKEKHAKEEDSSIDYDLNLPDTVTHEDYVTTRL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Phosphorylation | ---MAQFYYKRNVNA ---CCCCCCCCCCCC | 8.94 | 26074081 | |
6 | Phosphorylation | --MAQFYYKRNVNAP --CCCCCCCCCCCCC | 12.54 | 26074081 | |
14 | Phosphorylation | KRNVNAPYRDRIPLR CCCCCCCCCCCCCEE | 23.80 | 26074081 | |
32 | Phosphorylation | AESELSPSEKAYLNA CCCCCCHHHHHHHHH | 48.64 | 22985185 | |
167 | Phosphorylation | LLVQKGVSVPRPHEV HHHHCCCCCCCCCCC | 34.76 | 27174698 | |
193 | Phosphorylation | DVDSLRHSRSRLNIY CHHHHHHHHHHHHHH | 26.05 | 20068231 | |
195 | Phosphorylation | DSLRHSRSRLNIYKA HHHHHHHHHHHHHHH | 44.10 | 20068231 | |
200 | Phosphorylation | SRSRLNIYKALASPS HHHHHHHHHHHHCCC | 6.80 | 24260401 | |
205 | Phosphorylation | NIYKALASPSLIALS HHHHHHHCCCEEEEC | 18.83 | - | |
207 | Phosphorylation | YKALASPSLIALSSE HHHHHCCCEEEECCC | 29.88 | - | |
213 | Phosphorylation | PSLIALSSEDPFLTA CCEEEECCCCCHHHH | 47.04 | - | |
390 | O-linked_Glycosylation | ASQHIDRSDLNRQGP HHCCCCHHHHHCCCC | 42.58 | 29351928 | |
429 | Phosphorylation | WDGGLQDYIHDWWNL HCCCHHHHHHHHHHH | 6.28 | 24043423 | |
443 | Phosphorylation | LMDFVMNSLYLATIS HHHHHHHHHHHHHHH | 10.57 | 24043423 | |
445 | Phosphorylation | DFVMNSLYLATISLK HHHHHHHHHHHHHHH | 8.29 | 24043423 | |
448 | Phosphorylation | MNSLYLATISLKIVA HHHHHHHHHHHHHHH | 14.43 | 24043423 | |
450 | Phosphorylation | SLYLATISLKIVAFV HHHHHHHHHHHHHHH | 21.18 | 24043423 | |
489 | Phosphorylation | AIANIFSSLRLISLF HHHHHHHHHHHHHHH | 13.53 | 24719451 | |
523 | Phosphorylation | ILKFLFIYCLVLLAF HHHHHHHHHHHHHHH | 3.41 | 18083107 | |
538 | Phosphorylation | ANGLNQLYFYYEETK HCCCCHHHHEHHHHC | 4.64 | 18083107 | |
541 | Phosphorylation | LNQLYFYYEETKGLT CCHHHHEHHHHCCCE | 9.44 | 18083107 | |
624 | Phosphorylation | IAMMNNSYQLIADHA HHHHCCCHHHHHHCC | 14.95 | - | |
688 | Phosphorylation | KMRRKPESFGTIGRR HHHCCCHHCCHHHHH | 37.19 | 28674419 | |
706 | Phosphorylation | NLRRHHQYQEVMRNL HHHHHHHHHHHHHHH | 11.41 | 18083107 | |
781 | Phosphorylation | SADSDEKSDSEGNSK CCCCCCCCCCCCCCC | 44.30 | - | |
783 | Phosphorylation | DSDEKSDSEGNSKDK CCCCCCCCCCCCCCH | 55.27 | - | |
787 | Phosphorylation | KSDSEGNSKDKKKNF CCCCCCCCCCHHHCC | 53.76 | - | |
918 | Phosphorylation | HRERNTDTLGLQVGK CCCCCCCCCCCCCCC | 22.23 | 22210691 | |
955 | Phosphorylation | KHAKEEDSSIDYDLN HCCCCCCCCCCCCCC | 32.26 | 24275569 | |
956 | Phosphorylation | HAKEEDSSIDYDLNL CCCCCCCCCCCCCCC | 31.62 | 24275569 | |
959 | Phosphorylation | EEDSSIDYDLNLPDT CCCCCCCCCCCCCCC | 22.21 | 16144838 | |
972 | Phosphorylation | DTVTHEDYVTTRL-- CCCCHHHHCCCCC-- | 9.19 | 12154080 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
239 | S | Phosphorylation | Kinase | PRKG1 | Q13976 | GPS |
959 | Y | Phosphorylation | Kinase | FYN | P06241 | Uniprot |
972 | Y | Phosphorylation | Kinase | FYN | P06241 | Uniprot |
- | K | Ubiquitination | E3 ubiquitin ligase | ITCH | Q96J02 | PMID:17110928 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TRPC4_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TRPC4_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TRPC3_HUMAN | TRPC3 | physical | 12857742 | |
TRPC6_HUMAN | TRPC6 | physical | 12857742 | |
TRPC1_HUMAN | TRPC1 | physical | 12857742 | |
TRPC4_HUMAN | TRPC4 | physical | 12032305 | |
TRPC5_HUMAN | TRPC5 | physical | 12032305 | |
ITPR2_HUMAN | ITPR2 | physical | 11163362 | |
ITPR3_HUMAN | ITPR3 | physical | 11163362 | |
ITPR1_HUMAN | ITPR1 | physical | 11163362 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-193 AND SER-195, ANDMASS SPECTROMETRY. | |
"Epidermal growth factor induces tyrosine phosphorylation, membraneinsertion, and activation of transient receptor potential channel 4."; Odell A.F., Scott J.L., Van Helden D.F.; J. Biol. Chem. 280:37974-37987(2005). Cited for: FUNCTION, SUBCELLULAR LOCATION, PHOSPHORYLATION AT TYR-959 ANDTYR-972, AND MUTAGENESIS OF TYR-959 AND TYR-972. |